Australia markets close in 18 minutes

Zymergen Inc. (ZY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7700-0.0100 (-0.36%)
At close: 04:00PM EDT
2.7600 -0.01 (-0.36%)
After hours: 05:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.7800
Open2.8600
Bid0.0000 x 2200
Ask0.0000 x 1800
Day's range2.7300 - 2.9400
52-week range1.1000 - 14.1800
Volume837,781
Avg. volume1,332,120
Market cap289.063M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.6100
Earnings date12 May 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.30
  • Motley Fool

    Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future

    Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.

  • PR Newswire

    Ginkgo to Acquire Zymergen

    Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders will receive a